Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET

SEATTLE, July 30 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN)
management will host a conference call on Tuesday, August 11, 2009 at 8:30
a.m. PT; 11:30 a.m. ET to review second quarter 2009 financial results.
Access to the discussion may be obtained as follows:
Time: 11:30 AM ET /8:30 AM PT
Date: August 11, 2009
Dial-in: 1-877-548-7903 (domestic) or +1-719-325-4873 (international)
Webcast: www.dendreon.com (homepage and investor relations section)

A recorded rebroadcast will be available for interested parties unable to
participate in the live conference call by dialing 1-888-203-1112 or
+1-719-457-0820 for international callers; the conference ID number is
3674422. The replay will be available from 2:30 pm ET on Tuesday, August 11
until 11:59 pm ET on Thursday, August 13. In addition the webcast will be
archived for on-demand listening for 30 days at www.dendreon.com.

About Dendreon
Dendreon Corporation is a biotechnology company whose mission is to target
cancer and transform lives through the discovery, development and
commercialization of novel therapeutics. The Company applies its expertise in
antigen identification, engineering and cell processing to produce active
cellular immunotherapy product candidates designed to stimulate an immune
response. Dendreon is also developing an orally-available small molecule that
targets TRPM8 that could be applicable to multiple types of cancer as well as
benign prostatic hyperplasia. The Company has its headquarters in Seattle,
Washington and is traded on the Nasdaq Global Market under the symbol DNDN.
For more information about the Company and its programs, visit
www.dendreon.com.

SOURCE Dendreon Corporation

Jennifer Williams, Investor Relations of Dendreon Corporation ,
+1-206-829-1500